BioMarin Pharmaceutical
BMRN
#1863
Rank
โ‚น991.32 B
Marketcap
โ‚น5,154
Share price
-1.11%
Change (1 day)
-16.75%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): โ‚น58.09 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are โ‚น3.09 Billion. In 2024 the company made an earning of โ‚น50.37 Billion, an increase over its 2023 earnings that were of โ‚น17.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น58.09 B15.31%
2024 โ‚น50.37 B187.31%
2023 โ‚น17.53 B26.07%
2022 โ‚น13.90 B-298.51%
2021 -โ‚น7.01 Billion78.04%
2020 -โ‚น3.94 Billion-55.36%
2019 -โ‚น8.82 Billion-33.56%
2018 -โ‚น13.28 Billion297.78%
2017 -โ‚น3.34 Billion-95.68%
2016 -โ‚น77.29 Billion437.12%
2015 -โ‚น14.39 Billion23.91%
2014 -โ‚น11.62 Billion-29.25%
2013 -โ‚น16.42 Billion49.23%
2012 -โ‚น11 Billion171.11%
2011 -โ‚น4.06 Billion103.01%
2010 -โ‚น2 Billion-3903.54%
2009 โ‚น52.53 M-98.31%
2008 โ‚น3.10 B-189.7%
2007 -โ‚น3.47 Billion51.02%
2006 -โ‚น2.3 Billion-61.58%
2005 -โ‚น5.98 Billion-56.59%
2004 -โ‚น13.76 Billion95.13%
2003 -โ‚น7.05 Billion12.09%
2002 -โ‚น6.29 Billion73.19%
2001 -โ‚น3.64 Billion18.32%
2000 -โ‚น3.07 Billion19.65%
1999 -โ‚น2.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น846.24 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น48.24 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.14 Billion-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.56 Billion-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น0.46 B-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น26.57 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA